RxDoctor Payments Data

Michelle Alikpala

Nurse Practitioner · Marshfield, WINPI 1235679887

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $7,901 of the $11,848 with a category attached, or 66.7%. 12 manufacturers reported payments, led by Medtronic at 31.8% of the total. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,848in general payments, 2019–2025

Across 135 payments — averaging $87.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$4K
  • Edwards Lifesciences$3K
  • Boston Scientific$1K
  • Amgen$275
  • Johnson & Johnson$106
  • plus $266 from 6 others

What the payments were for

  • Travel & lodging$7,90167%
  • Food & beverage$3,92633%
  • Education$210%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,848 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$12,001
Medicare patients
81
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban30$21,707
XareltoRivaroxaban23$12,150
ClopidogrelClopidogrel Bisulfate100$695
Metoprolol Succinate21$208
Atorvastatin Calcium18$180
Methylprednisolone18$125
Losartan Potassium18$107
Amlodipine Besylate24$103
Ezetimibe13$95
Furosemide17$92
Metoprolol Tartrate16$64
Amoxicillin17$13
Famotidine14$11

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$106$12,15023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Marshfield

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →